Atrial fibrillation after thoracic surgery for lung cancer: Use of a single cut-off value of N-terminal pro-B type natriuretic peptide to identify patients at risk

Biomarkers

Volumn 15, Issue 3, 2010, Pages 259-265

  Salvatici, Michela ^a   Cardinale, Daniela ^a   Spaggiari, Lorenzo ^a   Veglia, Fabrizio ^b   Tedesco, Calogero Claudio ^b   Solli, Piergiorgio ^a   Cipolla, Carlo Maria ^a   Zorzino, Laura ^a   Passerini, Rita ^a   Riggio, Daniela ^a   Cassatella, Maria Cristina ^a   Sandri, Maria Teresa ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

Atrial fibrillation; Lung cancer disease; Natriuretic peptides; NT proBNP; Thoracic surgery

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CREATININE CLEARANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LUNG CANCER; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK MANAGEMENT; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; THORAX SURGERY;

AGED; AREA UNDER CURVE; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PEPTIDES; RISK; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 77951675837     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/13547500903509351     Document Type: Article

References (35)

1. ACC/AHA/ESC guidelines for the management of patients with atrial fbrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). (2001). J Am Coll Cardiol 38:1231-1265
2. Amar D. (2002). Post-operative atrial fbrillation. Heart Dis 4:117-123
3. Amar D, Shi W, Hogue CW Jr, Zhang H, Passman RS, Tomas B, Bach PB, Damiano R, Taler HT. (2004). Clinical prediction rule for atrial fbrillation after coronary artery bypass grafting. J Am Coll 44:1248-1253
4. Asamura H, Naruke T, Tsuchiya R, Goya T, Kondo H, Suemasu K. (1993). What are the risk factors for arrhythmias after thoracic operations? A retrospective multivariate analysis of 267 consecutive thoracic operations. J Torac Cardiovasc Surg 106:1104-1110
5. Ascione R, Caputo M, Calori G, Lloyd CT, Underwood MJ, Angelini GD. (2000). Predictors of atrial fbrillation after conventional and beating heart coronary surgery: a prospective, randomized study. Circulation 102:1530-1535
6. Auer J, Weber T, Berent R, Ng CK, Lamm G, Eber B. (2005). Risk factors of postoperative atrial fbrillation after cardiac surgery. J Card Surg 20:425-431
7. Brathwaite D, Weissman C. (1998). Te new onset of atrial arrhythmias following major non-cardiothoracic surgery is associated with increased mortality. Chest 114:462-468
8. Cardinale D, Martinoni A, Cipolla CM, Civelli M, Lamantia G, Fiorentini C, Mezzetti M. (1999). Atrial fbrillation after operation for lung cancer: clinical and prognostic signifcance. Ann Torac Surg 68:1827-1831
9. Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, Salvatici M, Veronesi G, Veglia F, Fiorentini C, Spaggiari L, Cipolla CM. (2007). Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fbrillation after thoracic surgery for lung cancer. Circulation 115:1339-1344.
10. Cowie MR, Struthers AD, Wood DA, Coats AJ, Tompson SG, Poole-Wilson PA, Sutton GC. (1997). Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350:1349-1353
11. Cofn M, Sukhatme S. (1997). Receiver operating characteristic studies and measurement errors. Biometrics 53:823-837
12. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, Clopton P, Alberto J, Hlavin P, Maisel AS. (2001). Utility of B-type natriuretic peptide (BNP) in the diagnosis of CHF in an urgent care setting. J Am Coll Cardiol 37:379-385
13. De Decker K, Jorens PG, Van Schil P. (2003). Cardiac complications after noncardiac thoracic surgery: an evidence-based current [Review]. Ann Torac Surg 75:1340-1348
14. Dernellis J, Panaretou M. (2006). Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients. Heart 92:1645-1650
15. Ellinor PT, Low AF, Patton KK, Shea MA, MacRae CA. (2005). Discordant atrial natriuretic peptide and brain natriuretic levels in lone atrial fbrillation. J Am Coll Cardiol 45:82-88
16. Goetze J P. (2004). Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited [Minireview]. Clin Chem 50:1503-1510
17. Hunt PJ, Richards AM, Nicholls NG, Yandle TG, Doughty RN, Espiner EA. (1997). Immunoreactive amino-terminal pro-brain natriu-retic peptide (NT-proBNP): a new marker of cardiac impairment. Clin Endocrinol 47:287-296
18. Hutfess R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, Clopton P, James C, Chiu A, Maisel AS. (2004). Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 43:1873-1879
19. Karthikeyan G, Moncur RA, Levine O, Heels-Ansdell D, Chan MT, Alonso-Coello P, Yusuf S, Sessler D, Villar JC, Berwanger O, McQueen M, Mathew A, Hill S, Gibson S, Berry C, Yeh HM, Devereaux PJ. (2009). Is a pre-operative brain natriuretic pep-tide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol 54:1599-1606
20. Kerbaul F, Collart F, Giorgi R, Oddoze C, Lejeune PJ, Guidon C, Caus T, Bellezza M, Gouin F. (2004). Increased plasma levels of pro-brain natriuretic peptide in patients with cardiovascular complications following of-pump coronary artery surgery. Intensive Care Med 30:1799-1806
21. Lee SH, Jung JH, Choi SH, Lee N, Park WJ, Oh DJ, Rhim CY, Lee KH. (2006). Determinants of brain natriuretic peptide levels in patients with lone atrial fbrillation. Circ J 70:100-104
22. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS. (2002). Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105:595-601.
23. McKie PM, Burnett JC. (2005). B-type natriuretic peptide as a biomar-ker beyond heart failure: speculations and opportunities. Mayo Clinic Proc 80:1029-1036
24. Mohamed MK, Ramalingam S, Lin Y, Gooding W, Belani CP. (2005). Skin rash and good performance status predict improved survival with geftinib in patients with advanced non-small cell lung cancer. Ann Oncol 16:780-785
25. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfsterer M, Perruchoud A P. (2004). Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350:647-654 (Pubitemid 38364623)
26. Ommen SR, Odell JA, Stanton MS. (1997). Atrial arrhythmias after car-diothoracic surgery [Review]. N Engl J Med 336:1429-1434
27. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-55.
28. Passman RS, Gingold DS, Amar D, Lloyd-Jones D, Bennett CL, Zhang H, Rusch VW. (2005). Prediction rule for atrial fbrillation after major noncardiac thoracic surgery. Ann Torac Surg 79:1698-1703
29. Patton KK, Ellinor P T, Heckbert SR, Christenson RH, DeFilippi C, Gottdiener JS, Kronmal RA.(2009). N-Terminal pro-B-type natriu-retic peptide is a major predictor of the development of atrial fbrillation. Circulation 120:1768-1774
30. Roselli EE, Murthy SC, Rice TW, Houghtaling PL, Pierce CD, Karchmer DP, Blackstone EH. (2005). Atrial fbrillation complicating lung cancer resection. J Torac Cardiovasc Surg 130:438-444
31. Seino Y, Ogawa A, Yamashita T, Fukushima M, Ogata K, Fukumoto H, Takano T. (2004). Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for detection and evaluation of heart failure. Eur J Heart Fail 15:295-300.
32. Struthers AD. (1994). Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? [Review]. BMJ 308:1615-1619
33. Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG, Walsh GL, Putnam JB Jr. (2004). Risk factors associated with atrial fbrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Torac Cardiovasc Surg 127:779-786
34. Wazni OM, Martin DO, Marrouche NF, Latif AA, Ziada K, Shaaraoui M, Almahameed S, Schweikert RA, Saliba WI, Gillinov AM, Tang WH, Mills RM, Francis GS, Young JB, Natale A. (2004). Plasma B-type natriuretic peptide levels predict postoperative atrial fbrillation in patients undergoing cardiac surgery. Circulation 110:124-127
35. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfeld MM. (1996). Superiority of brain natriuretic as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28:988-994